Selected article for: "control measure and influenza outbreak"
Author: Leung, Ho-Chuen; Chan, Chris Chung-Sing; Poon, Vincent Kwok-Man; Zhao, Han-Jun; Cheung, Chung-Yan; Ng, Fai; Huang, Jian-Dong; Zheng, Bo-Jian
Title: An H5N1-based matrix protein 2 ectodomain tetrameric peptide vaccine provides cross-protection against lethal infection with H7N9 influenza virus
  • Document date: 2015_4_8
    • ID: 14qckds8_26
    Snippet: To control potential new influenza pandemics, the best measure may be to develop a universal influenza vaccine because no existing vaccines can provide effective cross-protection against a mutated or reassorted novel influenza virus. Current efforts to develop universal vaccines include the development of M2e-based vaccines, HA stem vaccines 29 and M1 VLPs. 30 M2e-based vaccine candidates can provide cross-protection against infections of differe.....
    Document: To control potential new influenza pandemics, the best measure may be to develop a universal influenza vaccine because no existing vaccines can provide effective cross-protection against a mutated or reassorted novel influenza virus. Current efforts to develop universal vaccines include the development of M2e-based vaccines, HA stem vaccines 29 and M1 VLPs. 30 M2e-based vaccine candidates can provide cross-protection against infections of different subtypes of influenza virus. 20, 21, 31 In our previous studies, we showed that an H5N1-M2ebased tetrameric peptide vaccine exhibited promising protection against lethal challenge with different clades of H5N1 virus and other subtypes of influenza virus. 20, 21 In this study, we further demonstrated that this tetrameric peptide vaccine could also offer potent protection against infection with a novel H7N9 influenza virus, which caused a first outbreak from March to June 2013 and a second outbreak from November 2013 to December 2014 in China.

    Search related documents:
    Co phrase search for related documents
    • current effort and influenza virus: 1
    • different clade and influenza vaccine: 1
    • different clade and influenza virus: 1, 2
    • different clade and influenza virus subtype: 1
    • different clade and lethal challenge: 1, 2
    • different subtype and influenza pandemic: 1, 2
    • different subtype and influenza virus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
    • different subtype and influenza virus different subtype: 1, 2, 3, 4
    • different subtype and influenza virus subtype: 1, 2, 3, 4, 5, 6
    • different subtype and novel influenza virus: 1
    • exist vaccine and influenza vaccine: 1, 2, 3, 4
    • exist vaccine and influenza virus: 1, 2, 3
    • exist vaccine and lethal challenge: 1
    • influenza pandemic and new influenza pandemic: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • influenza pandemic and novel influenza virus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • influenza pandemic and peptide vaccine: 1, 2, 3, 4, 5, 6, 7
    • influenza pandemic and potent protection: 1, 2
    • influenza pandemic and potential new influenza pandemic: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • influenza pandemic and previous study: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14